V
Power Law company profile
Vectura
Biotech & Life Sciences · Chippenham, United Kingdom · Founded 1997 · IPO 2008 Unicorn
Valuation
$393M
Market cap · 2026
Revenue
$252M
Latest reported FY
Global footprint
Where Vectura has talent and traffic
Web traffic by country
650
monthly visits
across markets
across markets
🇬🇧 United Kingdom92.3%
🇳🇴 Norway15.4%
Patent intelligence
$208M patent portfolio · 99 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$208M
52.9% of market cap · comparable to top peer Arvinas ($223M)
99 active patent families
Where Vectura innovates
InhalationMedicinePhospholipidDrugInhalation Devices
Below peer median on Legal, Strategic, Economic, Technology
Quality vs same-sector peers
Vectura on the five Patsnap quality dimensions
Vectura in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Vectura concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Vectura and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Vectura on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.